Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. in September, 2014 for $489,072.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL123472-01 | Phase I | 489,072 | September 1, 2014 | |||||||
A SBIR Phase I contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $315,172.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI084296-01 | Phase I | 315,172 | ||||||||
A SBIR Phase II contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $473,340.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44ES0800013 | Phase II | 473,340 | ||||||||
A SBIR Phase I contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $149,866.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO110104 | Phase I | 149,866 | ||||||||
A SBIR Phase I contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $299,625.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201600014C-0-0-0 | Phase I | 299,625 | ||||||||
A SBIR Phase I contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $149,937.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO201000105 | Phase I | 149,937 | ||||||||
A SBIR Phase I contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $149,970.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO200900070 | Phase I | 149,970 | ||||||||
A SBIR Phase II contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $999,002.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CO110087 | Phase II | 999,002 | ||||||||
A SBIR Phase I contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $299,954.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO201000093 | Phase I | 299,954 | ||||||||
A SBIR Phase I contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $249,975.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CA130059 | Phase I | 249,975 | ||||||||
A SBIR Phase I contract was awarded to ROCKLAND IMMUNOCHEMICALS, INC. for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DA038982-01 | Phase I | 225,000 |